ESSA Pharma Inc. (EPIX)

ESSA Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	9	269	136	80	352	200
Market Cap Growth	-96.76%	97.31%	69.89%	-77.20%	75.80%	186.07%
Enterprise Value	-100	139	-16	-94	150	164
Last Close Price	0.20	0.75	0.38	0.23	0.99	0.85

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
PB Ratio	0.08	2.16	0.94	0.48	1.81	2.53
P/TBV Ratio	0.09	2.16	0.94	0.48	1.81	2.53

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Debt / Equity Ratio	-	0.00	0.00	0.00	0.00	0.00
Quick Ratio	68.84	38.45	42.41	72.39	49.73	65.35
Current Ratio	69.07	38.64	42.57	73.17	50.28	66.73
Return on Equity (ROE)	-21.25%	-21.13%	-17.00%	-19.44%	-26.94%	-36.57%
Return on Assets (ROA)	-15.25%	-15.52%	-12.61%	-12.57%	-16.66%	-21.75%
Return on Invested Capital (ROIC)	-15.57%	-15.90%	-12.83%	-12.77%	-16.97%	-22.27%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Earnings Yield	-265.43%	-10.62%	-19.51%	-43.76%	-10.46%	-11.71%
FCF Yield	-219.42%	-8.45%	-14.52%	-34.91%	-7.22%	-8.48%
Buyback Yield / Dilution	-0.40%	-0.43%	-0.12%	-14.44%	-71.45%	-166.13%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error